Ocugen (OCGN) Amortizatization of Intangibles (2017 - 2023)

Ocugen's (OCGN) quarterly Amortizatization of Intangibles came in at $39000.0 in Q2 2023, down 72.73% on a QoQ basis from $143000.0 in Q1 2023.

Analysis

Ocugen (OCGN) Amortizatization of Intangibles (2017 - 2023) Analysis & Trends

Ocugen (OCGN) has 3 years of Amortizatization of Intangibles data on file, last reported at $39000.0 in Q2 2023.

Quarterly Amortizatization of Intangibles changed N/A year-over-year to $39000.0 in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $39000.0 (down 83.88% YoY) and the FY2023 annual result came in at $182000.0, up 83.84% from the prior year.
Amortizatization of Intangibles retreated to $39000.0 in Q2 2023, from $143000.0 in the prior quarter.
In the past five years, Amortizatization of Intangibles ranged from a high of $143000.0 in Q1 2023 to a low of $39000.0 in Q2 2023.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Amortizatization of Intangibles (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	-
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	-
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	4.33 Mn
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	678,000.00
10	Ocugen	458.91 Mn	358.81 Mn	-	-

Historic Data

Download Data